<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Mayfield HJ</submitter><funding>Bill &amp; Melinda Gates Foundation</funding><funding>Australian National Health and Medical Research Council</funding><pagination>311</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11680324</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9(12)</volume><pubmed_abstract>The elimination of lymphatic filariasis (LF) as a public health problem remains an ongoing challenge in the Pacific region. This study reports on antigen (Ag) and microfilaria (Mf) prevalence in Samoa in 2019, 7-9 months after the completion of the first round of triple-drug mass drug administration (MDA). It evaluates the effectiveness of the intervention for reducing Ag prevalence to below a 2% threshold, and how this differs between 5-9-year-olds and ≥10-year-olds. We surveyed 30 randomly selected and five purposefully selected primary sampling units (PSUs) in Samoa in 2018 (1-3 months post-triple-drug MDA) and, again, in 2019. In each PSU, we conducted a community survey of 15-20 households and a convenience survey of 5-9-year-old children. A finger-prick blood sample was collected fro</pubmed_abstract><journal>Tropical medicine and infectious disease</journal><pubmed_title>Epidemiology of Lymphatic Filariasis Antigen and Microfilaria in Samoa, 2019: 7-9 Months Post Triple-Drug Mass Administration.</pubmed_title><pmcid>PMC11680324</pmcid><funding_grant_id>OPP1190754</funding_grant_id><funding_grant_id>APP1158469</funding_grant_id><pubmed_authors>Sartorius B</pubmed_authors><pubmed_authors>Gass K</pubmed_authors><pubmed_authors>Graves PM</pubmed_authors><pubmed_authors>Lau CL</pubmed_authors><pubmed_authors>Mayfield HJ</pubmed_authors><pubmed_authors>Sheridan S</pubmed_authors><pubmed_authors>Kearns T</pubmed_authors><pubmed_authors>Hedtke SM</pubmed_authors><pubmed_authors>Naseri T</pubmed_authors><pubmed_authors>Thomsen R</pubmed_authors><pubmed_authors>Lawford H</pubmed_authors></additional><is_claimable>false</is_claimable><name>Epidemiology of Lymphatic Filariasis Antigen and Microfilaria in Samoa, 2019: 7-9 Months Post Triple-Drug Mass Administration.</name><description>The elimination of lymphatic filariasis (LF) as a public health problem remains an ongoing challenge in the Pacific region. This study reports on antigen (Ag) and microfilaria (Mf) prevalence in Samoa in 2019, 7-9 months after the completion of the first round of triple-drug mass drug administration (MDA). It evaluates the effectiveness of the intervention for reducing Ag prevalence to below a 2% threshold, and how this differs between 5-9-year-olds and ≥10-year-olds. We surveyed 30 randomly selected and five purposefully selected primary sampling units (PSUs) in Samoa in 2018 (1-3 months post-triple-drug MDA) and, again, in 2019. In each PSU, we conducted a community survey of 15-20 households and a convenience survey of 5-9-year-old children. A finger-prick blood sample was collected fro</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Dec</publication><modification>2025-04-04T02:36:06.643Z</modification><creation>2025-04-04T02:36:06.643Z</creation></dates><accession>S-EPMC11680324</accession><cross_references><pubmed>39728838</pubmed><doi>10.3390/tropicalmed9120311</doi></cross_references></HashMap>